The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,378.16 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V Program, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The contract is an unrestricted, non-set-aside award, allowing Dakota Drug, Inc. to continue serving as a key strategic supplier of pharmaceutical and medical products to support U.S. Armed Forces medical operations.
Generated 3/3/25, 12:28 PM